Cargando…

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042

The frequent dysregulation of SRC family kinases (SFK) in multiple cancers prompted various inhibitors to be actively tested in preclinical and clinical trials. Disappointingly, dasatinib and saracatinib failed to demonstrate monotherapeutic efficacy in patients with head and neck squamous cell carc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermida-Prado, Francisco, Villaronga, M. Ángeles, Granda-Díaz, Rocío, del-Río-Ibisate, Nagore, Santos, Laura, Hermosilla, Maria Ana, Oro, Patricia, Allonca, Eva, Agorreta, Jackeline, Garmendia, Irati, Tornín, Juan, Perez-Escuredo, Jhudit, Fuente, Rocío, Montuenga, Luis M., Morís, Francisco, Rodrigo, Juan P., Rodríguez, René, García-Pedrero, Juana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722627/ https://www.ncbi.nlm.nih.gov/pubmed/31382448 http://dx.doi.org/10.3390/jcm8081157

Ejemplares similares

Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2
por: Pandiella, Atanasio, et al.
Publicado: (2015)

The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
por: Federico, Aniello, et al.
Publicado: (2020)

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
por: Tornin, Juan, et al.
Publicado: (2016)

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042)
por: Fernández-Guizán, Azahara, et al.
Publicado: (2015)

The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling
por: Lorenzo-Herrero, Seila, et al.
Publicado: (2019)

Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets
por: Álvarez-Teijeiro, Saúl, et al.
Publicado: (2018)

Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
por: Hermida-Prado, Francisco, et al.
Publicado: (2018)

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
por: Redin, Esther, et al.
Publicado: (2021)

Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin
por: Menéndez-Menéndez, Javier, et al.
Publicado: (2019)

SOX2 Expression Is an Independent Predictor of Oral Cancer Progression
por: de Vicente, Juan C., et al.
Publicado: (2019)

Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020)

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions
por: Rodrigo, Juan P., et al.
Publicado: (2017)

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models()
por: Martinez-Cruzado, Lucia, et al.
Publicado: (2017)

Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas
por: Sánchez-Canteli, Mario, et al.
Publicado: (2022)

Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b
por: Álvarez-Teijeiro, Saúl, et al.
Publicado: (2017)

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014)

Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations
por: Martinez-Cruzado, Lucia, et al.
Publicado: (2016)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

The diverse lives of TRAP1
por: Agorreta, Jackeline, et al.
Publicado: (2014)

Lactate does not activate NF-κB in oxidative tumor cells
por: Van Hée, Vincent F., et al.
Publicado: (2015)

HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms
por: Menéndez, Sofía T., et al.
Publicado: (2016)

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
por: García-Carracedo, Darío, et al.
Publicado: (2016)

Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients
por: Grbesa, Ivana, et al.
Publicado: (2015)

Benign Lesions in Mucosa Adjacent to Intestinal-Type Sinonasal Adenocarcinoma
por: Vivanco, Blanca, et al.
Publicado: (2011)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Monocarboxylate transporters in the brain and in cancer()
por: Pérez-Escuredo, Jhudit, et al.
Publicado: (2016)

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
por: Abou Faycal, Cherine, et al.
Publicado: (2018)

Identification of Importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens
por: Nguewa, Paul A, et al.
Publicado: (2008)

Host Genetics and Microbiota Interactions in Colorectal Cancer: Shared or Independent Risk?
por: Romero-Garmendia, Irati, et al.
Publicado: (2022)

From Omic Layers to Personalized Medicine in Colorectal Cancer: The Road Ahead
por: Romero-Garmendia, Irati, et al.
Publicado: (2023)

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2023)

The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions
por: Granda-Díaz, Rocío, et al.
Publicado: (2019)

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
por: Valencia, Karmele, et al.
Publicado: (2022)

Complement C4d-specific antibodies for the diagnosis of lung cancer
por: Ajona, Daniel, et al.
Publicado: (2017)

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
por: Pajares, M J, et al.
Publicado: (2014)

Glioblastoma Immune Landscape and the Potential of New Immunotherapies
por: Daubon, Thomas, et al.
Publicado: (2020)

FSMP-14. METABOLIC SYMBIOSIS IN GLIOBLASTOMA: LACTATE DEHYDROGENASES TAKE THE LEAD
por: Guyon, Joris, et al.
Publicado: (2021)

The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders
por: de Vicente, Juan C., et al.
Publicado: (2019)

Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer
por: Pio, Ruben, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9fgquhsvnipi2shpbo3vqi2ckr